SERINA THERAPEUTICS INC. (SER) Stock Cash Flow
NYSEARCA:SER • US81751A1088
Current stock price
2.05 USD
+0.06 (+3.02%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.21M | -11.21M | -14.80M | -10.46M | -8.58M | |||
| Depreciation Amortization | 73.00K | 194.00K | 131.00K | 130.00K | 130.00K | |||
| Change In Working Capital | 1.47M | -3.32M | 1.54M | 330.00K | -880.00K | |||
| Interest Paid | 17.00K | N/A | 27.00K | 10.00K | 10.00K | |||
| Other non cash items | -283.00K | -2.81M | 5.33M | 4.06M | 1.48M | |||
| OPERATING CASH FLOW | -17.95M | -17.14M | -7.80M | -5.94M | -7.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -59.00K | -22.00K | N/A | N/A | 0.00 | |||
| Other Investing Activity | N/A | N/A | -10.00M | 0.00 | 670.00K | |||
| INVESTING CASH FLOW | -59.00K | -22.00K | -10.00M | 0.00 | 670.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 4.91M | 2.88M | 17.50M | 6.00M | 7.00M | |||
| Stock Issued/Repurchased | 12.50M | 10.00M | N/A | 0.00 | 500.00K | |||
| Other Financing Activity | 0.00 | 337.00K | N/A | 0.00 | -250.00K | |||
| FINANCING CASH FLOW | 17.41M | 13.21M | 17.50M | 6.00M | 7.25M | |||
| Exchange Rate Effect | -14.00K | N/A | N/A | N/A | 0.00 | |||
| CHANGE IN CASH | -616.00K | -3.95M | -300.00K | 60.00K | 60.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.95M | -17.14M | -7.80M | -5.94M | -7.86M | |||
| Capital Expenditure | -59.00K | -22.00K | N/A | N/A | 0.00 | |||
| FREE CASH FLOW | -18.01M | -17.16M | -7.80M | -5.94M | -7.86M | |||
All data in USD